Partnering with Apitope

Apitope expects to explore potential partnership opportunities for the further development and commercialisation of its product candidates and aims to become the partner of choice for pharmaceutical companies developing disease-modifying therapies for autoimmune diseases and other undesired immune responses.


Hayley French

Chief Business Officer & General Counsel

You can contact Hayley here by choosing the 'Partnering Contact' option.